Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
Title:
Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
Author:
Eide, Christopher A. Brewer, Diana Xie, Tao Schultz, Anna Reister Savage, Samantha L. Muratcioglu, Serena Merz, Noah Press, Richard D. O’Hare, Thomas Jacob, Thomas Vu, Tania Q. Tognon, Cristina E. Macey, Tara A. Kuriyan, John Kalodimos, Charalampos G. Druker, Brian J.